Status:
COMPLETED
Dementia Symptom Management at Home Program
Lead Sponsor:
NYU Langone Health
Conditions:
Dementia
Eligibility:
All Genders
65+ years
Phase:
NA
Brief Summary
Alzheimer's Disease and Related Disorders (dementia) poses a significant challenge to our public health. While many persons with dementia are cared for by friends and family in the community with the ...
Eligibility Criteria
Inclusion
- PWD over the age of 65
- Admitted to one of the three HHC agencies
- The patient and family caregiver speak English and/or Spanish.
- The informal caregiver is ≥18 years of age and spends at least 8 hours per week with the patient.
- Patients who score ≥6 on the Quick Dementia Rating Scale (at least mild impairment).
Exclusion
- Patients with a separate Axis 1 diagnosis other than forms of dementia, depression or anxiety.
- PWD residing in assisted living facilities or board and care homes
- PWD solely receiving infusion or home health aide services.
Key Trial Info
Start Date :
August 16 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 31 2022
Estimated Enrollment :
217 Patients enrolled
Trial Details
Trial ID
NCT03255967
Start Date
August 16 2018
End Date
May 31 2022
Last Update
January 30 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
New York University School of Medicine
New York, New York, United States, 10016